From Mila to Millions: Scaling N of 1 Therapies

Julia Vitarello, CEO of Mila’s Miracle Foundation, discusses the N=1 Collaborative, which she co-founded, the issues it is trying to address, and what it would take to take enable the development of individualized therapies broadly for patients with ultra-rare disease.